磁共振波谱中肌醇浓度用于鉴别高级别胶质瘤与原发性中枢神经系统淋巴瘤
研究纳入104例脑肿瘤患者(66例胶质瘤、20例原发性中枢神经系统淋巴瘤、6例转移瘤、12例其他肿瘤),术前采用短回波时间(35 ms)单体素3-T磁共振波谱(MRS)及LCModel软件评估代谢物绝对浓度。高级别胶质瘤的肌醇(mIns)水平显著高于原发性中枢神经系统淋巴瘤(p < 0.001),多因素logistic回归中mIns是鉴别两者的最佳标志物(p < 0.0001,比值比1.9927,95%置信区间1.3628-3.2637);常规MRS检测mIns诊断高级别胶质瘤的敏感度64%、特异度90%、受试者工作特征曲线下面积0.80。胶质瘤中肌醇3-磷酸合酶(ISYNA1)表达显著高于原发性中枢神经系统淋巴瘤(p < 0.05),提示胶质瘤mIns升高与ISYNA1高表达有关。
要点
- 高级别胶质瘤mIns水平显著高于原发性中枢神经系统淋巴瘤(p < 0.001)。
- 多因素logistic回归中mIns鉴别高级别胶质瘤与原发性中枢神经系统淋巴瘤的比值比1.9927(95%置信区间1.3628-3.2637,p < 0.0001)。
- 常规MRS检测mIns诊断高级别胶质瘤的敏感度64%、特异度90%、曲线下面积0.80。
核心结论
- 无创单体素MRS分析mIns可能有助于鉴别胶质瘤与其他脑肿瘤,尤其是原发性中枢神经系统淋巴瘤。
研究设计与样本
- 共104例脑肿瘤患者(66例胶质瘤、20例原发性中枢神经系统淋巴瘤、6例转移瘤、12例其他肿瘤)术前接受短回波时间(35 ms)单体素3-T MRS检查,并用LCModel软件评估代谢物绝对浓度。
主要发现
- 高级别胶质瘤mIns水平显著高于原发性中枢神经系统淋巴瘤(p < 0.001)。
- 多因素logistic回归分析中mIns是鉴别高级别胶质瘤与原发性中枢神经系统淋巴瘤的最佳标志物(p < 0.0001,比值比1.9927,95%置信区间1.3628-3.2637)。
- 常规MRS检测mIns诊断高级别胶质瘤的敏感度64%、特异度90%、受试者工作特征曲线下面积0.80。
- 胶质瘤中ISYNA1表达显著高于原发性中枢神经系统淋巴瘤(p < 0.05),提示胶质瘤mIns升高与ISYNA1高表达有关。
关键数值与推荐
- 高级别胶质瘤mIns水平较原发性中枢神经系统淋巴瘤显著升高(p < 0.001)。
- mIns鉴别高级别胶质瘤与原发性中枢神经系统淋巴瘤的比值比1.9927(95%置信区间1.3628-3.2637,p < 0.0001)。
- 常规MRS检测mIns诊断高级别胶质瘤的敏感度64%、特异度90%、曲线下面积0.80。
- 胶质瘤ISYNA1表达较原发性中枢神经系统淋巴瘤显著升高(p < 0.05)。
临床怎么用
- 原文结论认为无创单体素MRS分析mIns可能有助于鉴别胶质瘤与其他脑肿瘤,尤其是原发性中枢神经系统淋巴瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It is sometimes difficult to distinguish gliomas from other tumors on routine imaging. In this study, we assessed whether 3-T magnetic resonance spectroscopy (MRS) with LCModel software might be useful for discriminating glioma from other brain tumors, such as primary central nervous system lymphomas (PCNSLs) and metastatic tumors. A total of 104 cases of brain tumor (66 gliomas, 20 PCNSLs, 6 metastatic tumors, 12 other tumors) were preoperatively investigated with short echo time (35 ms) single-voxel 3-T MRS. LCModel software was used to evaluate differences in the absolute concentrations of choline, N-acetylaspartate, N-acetylaspartylglutamate, glutamate + glutamine, myo-inositol (mIns), and lipid. mIns levels were significantly increased in high-grade glioma (HGG) compared with PCNSL (p < 0.001). In multivariate logistic regression analysis, mIns was the best marker for differentiating HGG from PCNSL (p < 0.0001, odds ratio 1.9927, 95% confidence interval 1.3628-3.2637). Conventional MRS detection of mIns resulted in a high diagnostic accuracy (sensitivity, 64%; specificity, 90%; area under the receiver operator curve, 0.80) for HGG. The expression of inositol 3-phosphate synthase (ISYNA1) was significantly higher in gliomas than in PCNSLs (p < 0.05), suggesting that the increased level of mIns in glioma is due to high expression of ISYNA1, the rate-limiting enzyme in the mIns-producing pathway. In conclusion, noninvasive analysis of mIns using single-voxel MRS may be useful in distinguishing gliomas from other brain tumors, particularly PCNSLs.
引用
- Nagashima H, Sasayama T, Tanaka K, et al. Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma. J Neurooncol. 2017. PMID: 29143277. doi:10.1007/s11060-017-2655-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。